BOT 2.03% 37.8¢ botanix pharmaceuticals ltd

BOT: Moving Forward, page-4

  1. 790 Posts.
    lightbulb Created with Sketch. 141
    A phase 2 showing convincing effectiveness for AD would be a slam dunk and company maker on its own...the safety profile being well established.

    The addressable market dwarfs acne.

    The world needs a treatment for AD that you can use on babies.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.